Call for eye health professionals to participate in charity survey

Article

Fight for Sight is calling for eye health professionals to participate in the Sight Loss and Vision Survey to aid the future development of eye research.

Fight for Sight is calling for eye health professionals to participate in the Sight Loss and Vision Survey to aid the future development of eye research.

The NIHR Biomedical Research Centre for Ophthalmology, the Royal College of Ophthalmologists, the RNIB and UK Vision strategy are working together to launch the Sight Loss and Vision Survey.

Anyone involved in the ophthalmic field will be able to complete the survey and put forward any questions about further eye research. The results of the survey will be used to prioritize the needs of people with sight loss, their carers and eye health professionals.

Chief executive of Fight for Sight, Michele Acton, said, "With limited resources available, it is crucial that eye health professionals have their say in prioritizing medical research into the prevention, diagnosis and treatment of eye disease. For the first time, the Sight Loss and Vision Survey will allow eye health specialists to do just that. We hope that as many professionals as possible working in the field of eye health all over the UK take part and tell us which questions they want research to answer.”

For those who want to take part in the survey please visit www.sightlosspsp.org.uk Large print and Braille versions are available on request.,/p>

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.